Animal Health Leadership Team
Mark Colgin, Ph.D.
Vice President of Animal Health
With 20+ years of research and development experience, Mark Colgin, PhD was appointed Chief Scientific Officer of the Company in February 2009. Dr. Colgin joined the Company in September 2000 and served as Director of Recombinant Technology until he was promoted to Chief Scientist in January 2003. Prior to joining the Company, his areas of research included the characterization and artificial synthesis of spider silk proteins, regulation of gene expression, neurovirology and gene delivery systems. Dr. Colgin received a B.S. in Biochemistry and a Ph.D. in Molecular Biology from the University of Wyoming.
Dr. Andrew Peters, DVM, Ph.D.
Animal Health Consultant
Dr. Peters joined the Company in October 2009 and brings more than 30 years of experience in the animal health market, including significant experience successfully completing regulatory, business development, strategic alliance and technology transfer activities. During his eight years with Pfizer Animal Health, he served in a number of senior positions and lastly as senior director of EU Vaccine R&D. He previously was a professor of animal health and production at the Royal Veterinary College of University of London from 1993 to 1998. Dr. Peters is a veterinarian with PhD and DSc degrees in animal science and holds a special professorship with the University of Nottingham. He has authored more than 145 papers in physiology, animal science and vaccine development, and has published two books. He is also a frequent speaker within the industry.